GH1 and COVID-19: Our data show that the severe forms of COVID-19 are associated with an impairment of the GH–IGF-1 axis, along with higher BMI, higher ferritin levels, and reduced liver attenuation on non-contrast CT, all of which are associated with an increased likelihood of ventilation or death.